Inhibrx Biosciences experiences a significant rise in global media mentions, indicating increased interest and attention to the biotech company’s developments.
The president has signed an executive order related to vaccines, impacting public health policy. Details on scope and implementation are still emerging.
Recent reports show rising cases of Candida auris infections in hospitals across the US, raising concerns about antimicrobial resistance and infection control.
